In vivo

  1. Gut microbiome helps shape Parkinson’s drug interactions
    Drug-microbiome-drug interaction study reveals how COMT inhibitors used with levodopa alter gut bacteria and affect medication metabolism in Parkinson's patients.
  2. Microneedle biosensor tracked drug clearance and organ dysfunction
    Wearable microneedle biosensors with durable nanostructured electrodes continuously monitor drug clearance to detect liver and kidney dysfunction in real time.